Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 Clinical Trial
Year: 2012
Type: article
Study design: Clinical Trial
Source: Neurology
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: alemtuzumab, interferon beta-1a, relapsing-remitting multiple sclerosis, long-term efficacy, disability progression, relapse rate, treatment safety, serious infections, thyroid dysfunction, idiopathic thrombocytopenic purpura, long-term follow-up, immunomodulatory therapy, B-cell depletion
Open Access status: closed
OpenAlex ID: W2107422246
